Pharmaceutical Preparations · DE · CIK 728387
Develops radiopharmaceuticals using Lead-212 to deliver radiation specifically to cancer cells
Comparable business profile · signals at a glance
In the 90 days to Nov 13, 2025: 2 insiders bought $42K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 13, 2025 | Hunt Jonathan RobertChief Accounting Officer | Buy | 11,000 | $2.03 | $22K |
| Nov 12, 2025 | Williamson Robert F IiiDirector | Buy | 9,498 | $2.10 | $20K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.